Baylor Irving now offers a new FDA-approved screening to help diagnose Alzheimer’s. People who have warning signs for Alzheimer’s disease, such as memory loss, forgetfulness or trouble finding the words to form their thoughts, now have a new option at Baylor Irving.  The U.S. Food and Drug Administration has approved a radioactive isotope that, when injected, attaches to plaque buildups associated with Alzheimer’s disease and lights up on a PET scan. For the test, after the isotope injection the patient waits about 30 minutes, then doctors run a PET scan to look for signs of the plaque.
People who are at high risk for lung cancer can take advantage of a new lung cancer screening program at Baylor Irving. The screening involves a simple, low-dose CT scan of the lungs that takes about 30 seconds. A radiologist reviews the scan and looks for signs of nodules that might indicate cancer. Patients with lung cancer typically have no symptoms until the disease is advance. This is a screening tool that can potentially save lives. Depending on the findings, doctors may recommend a repeat scan in a year, bronchoscope, PET scan, biopsy or referral to the Baylor Irving chest mass clinic.
For more information about the New Screenings Available at Baylor Irving click here.
Print Friendly